Cardiovascular Institute, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Free Radic Biol Med. 2009 Oct 15;47(8):1140-6. doi: 10.1016/j.freeradbiomed.2009.07.025. Epub 2009 Jul 22.
Elevated plasma fibrinogen is a prothrombotic risk factor for cardiovascular disease (CVD). Recent small studies report that fibrinogen oxidative modifications, specifically tyrosine residue nitration, can occur in inflammatory states and may modify fibrinogen function. HDL cholesterol is inversely related to CVD and suggested to reduce the oxidation of LDL cholesterol, but whether these antioxidant functions extend to fibrinogen modifications is unknown. We used a recently validated ELISA to quantify nitrated fibrinogen during experimental human endotoxemia (N=23) and in a cohort of healthy adults (N=361) who were characterized for inflammatory and HDL parameters as well as subclinical atherosclerosis measures, carotid artery intima-medial thickness (IMT) and coronary artery calcification (CAC). Fibrinogen nitration increased following endotoxemia and directly correlated with accelerated ex vivo plasma clotting velocity. In the observational cohort, nitrated fibrinogen was associated with levels of CRP and serum amyloid A. Nitrated fibrinogen levels were not lower with increasing HDL cholesterol and did not associate with IMT and CAC. In humans, fibrinogen nitration was induced during inflammation and was correlated with markers of inflammation and clotting function but not HDL cholesterol or subclinical atherosclerosis in our modest sample. Inflammation-induced fibrinogen nitration may be a risk factor for promoting CVD events.
血浆纤维蛋白原升高是心血管疾病 (CVD) 的促血栓形成风险因素。最近的一些小型研究报告称,纤维蛋白原的氧化修饰,特别是酪氨酸残基硝化,可能发生在炎症状态下,并可能改变纤维蛋白原的功能。高密度脂蛋白胆固醇与 CVD 呈负相关,并被认为可以降低 LDL 胆固醇的氧化,但这些抗氧化功能是否扩展到纤维蛋白原的修饰尚不清楚。我们使用最近验证的 ELISA 在人类内毒素血症的实验中(N=23)和在一个健康成年人队列中(N=361)定量测定纤维蛋白原的硝化,该队列的特征是炎症和高密度脂蛋白参数以及亚临床动脉粥样硬化指标,颈动脉内膜中层厚度 (IMT) 和冠状动脉钙化 (CAC)。内毒素血症后纤维蛋白原硝化增加,并与体外加速血浆凝固速度直接相关。在观察性队列中,硝化纤维蛋白原与 CRP 和血清淀粉样蛋白 A 的水平相关。纤维蛋白原硝化水平与高密度脂蛋白胆固醇的增加无关,与 IMT 和 CAC 也无关。在人类中,纤维蛋白原硝化在炎症期间被诱导,与炎症标志物和凝血功能标志物相关,但与我们适度样本中的高密度脂蛋白胆固醇或亚临床动脉粥样硬化无关。炎症诱导的纤维蛋白原硝化可能是促进 CVD 事件的风险因素。